Goldman Sachs raises Abivax stake to 5.55%, crossing 5% threshold
GS•Goldman Sachs crossed above 5% of Abivax’s capital and voting rights on September 28, 2026, after an off-market share acquisition. Its indirect holding reached 4,840,036 shares, equal to 5.55% of capital and 5.47% of voting rights.
1. Stake disclosure
Goldman Sachs crossed above 5% of Abivax’s capital and voting rights on September 28, 2026, through an off-market share acquisition. Its indirect holding reached 4,840,036 shares, representing 5.55% of capital and 5.47% of voting rights.
